Triphenylphosphine-Modified Iridium III , Rhodium III , and Ruthenium II Complexes to Achieve Enhanced Anticancer Selectivity by Targeting Mitochondria
Inorganic Chemistry · 30.12.2024 · 63 (52) · 24736-24753
DOI: 10.1021/acs.inorgchem.4c03975 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, online erschienen am 16.12.2024. Verfasst von Zhe Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Life-Organic Analysis of Shandong Province, Key Laboratory of Green Natural Products and Pharmaceutical Intermediates in Colleges a…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Mitochondria, Coordination Complexes, Organophosphorus Compounds. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 98 Literaturangaben. Gefördert von: Taishan Scholar Project of Shandong Province, Natural Science Foundation of Shandong Province, Young Talents Invitation Program of Shandong Provincial Colleges and Universities.
Abstract (Originalsprache)
The incorporation of an organelle-targeting moiety into compounds has proven to be an effective strategy in the development of targeted anticancer drugs. We herein report the synthesis, characterization, and biological evaluation of novel triphenylphosphine-modified half-sandwich iridiumIII, rhodiumIII, and rutheniumII complexes. The primary goal was to enhance anticancer selectivity through mitochondrial targeting. All these triphenylphosphine-modified complexes exhibited promising cytotoxicity in the micromolar range (5.13-23.22) against A549 and HeLa cancer cell lines, surpassing the activity of comparative complexes that lack the triphenylphosphine moiety. Noteworthy is their good selectivity toward cancer cells compared to normal BEAS-2B cells, underscored by selectivity index ranging from 7.3 to >19.5. Mechanistically, these complexes primarily target mitochondria rather than interacting with DNA. The targeting of mitochondria and triggering mitochondrial dysfunction were confirmed using both confocal microscopy and flow cytometry. Their ability to depolarize mitochondrial membrane potential (MMP) and enhance reactive oxygen species (ROS) was observed, thereby leading to intrinsic apoptotic pathways. Moreover, these complexes lead to cell cycle arrest in the G2/M phase and demonstrated antimigration effects, significantly inhibiting the migration of A549 cells in wound-healing assays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Life-Organic Analysis of Shandong Province, Key Laboratory of Green Natural Products and Pharmaceutical Intermediates in Colleges and Universities of Shandong Province, School of Chemistry and Chemical…
Förderung
- Taishan Scholar Project of Shandong Province
- Natural Science Foundation of Shandong Province
- Young Talents Invitation Program of Shandong Provincial Colleges and Universities
Zitieren
APA
Liu, Z., Fu, H., Dong, H., Lai, K., Yang, Z., Fan, C., Luo, Y., Qin, W., & Guo, L. (2024). Triphenylphosphine-Modified Iridium III , Rhodium III , and Ruthenium II Complexes to Achieve Enhanced Anticancer Selectivity by Targeting Mitochondria. Inorganic Chemistry, 63(52), 24736-24753. https://doi.org/10.1021/acs.inorgchem.4c03975
Vancouver
Liu Z, Fu H, Dong H, Lai K, Yang Z, Fan C, et al. Triphenylphosphine-Modified Iridium III , Rhodium III , and Ruthenium II Complexes to Achieve Enhanced Anticancer Selectivity by Targeting Mitochondria. Inorganic Chemistry. 2024;63(52):24736-24753. doi:10.1021/acs.inorgchem.4c03975
BibTeX
@article{Liu2024,
author = {Liu, Zhe and Fu, Hanxiu and Dong, Heqian and Lai, Kangning and Yang, Zhihao and Fan, Chunyan and Luo, Yuting and Qin, Wenting and Guo, Lihua},
title = {Triphenylphosphine-Modified Iridium III , Rhodium III , and Ruthenium II Complexes to Achieve Enhanced Anticancer Selectivity by Targeting Mitochondria},
journal = {Inorganic Chemistry},
year = {2024},
volume = {63},
number = {52},
pages = {24736--24753},
doi = {10.1021/acs.inorgchem.4c03975}
}
EUVIMED